Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27,767,902
-
Total 13F shares
-
19,365,073
-
Share change
-
+566,225
-
Total reported value
-
$1,100,212,074
-
Put/Call ratio
-
0%
-
Price per share
-
$56.81
-
Number of holders
-
139
-
Value change
-
+$34,210,945
-
Number of buys
-
48
-
Number of sells
-
81
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q3 2021
As of 30 Sep 2021,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
139 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,365,073 shares.
The largest 10 holders included
BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, STATE STREET CORP, FIRST MANHATTAN CO, NORTHERN TRUST CORP, Krensavage Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
139
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.